Compare CBD of Denver (CBDD) With Other Cannabis Stocks
Head-to-head stock comparisons across price, valuation, financials, and growth metrics
CBD of Denver (CBDD)
$43.74
+2.70%
$3.21B
CBD
CBD Sector Peers
All CBD cannabis companies sorted by market capitalization. Click any ticker to see a detailed head-to-head comparison.
| Ticker | Name | Price | Change % | MCap |
|---|---|---|---|---|
| CWBHF | Charlotte's Web Holdings | $0.62 | -0.22% | $99.3M |
| PKANF | Simply Better Brands | $0.21 | 0.00% | $22.2M |
| YCBD | cbdMD Inc | $0.71 | -0.75% | $7.5M |
| PCLOF | PharmaCielo | $0.04 | -26.40% | $7.4M |
| OILFF | Nextleaf Solutions | $0.04 | +1.93% | $7.1M |
| CVSI | CV Sciences | $0.04 | -12.42% | $6.5M |
| DHBUF | Delivra Health Brands | $0.14 | +10.51% | $4.4M |
| ELLXF | Elixinol Global | $0.01 | 0.00% | $1.9M |
| CBDNF | CBD Global Sciences | $0.04 | +16.39% | $1.8M |
| GBHPF | Global Hemp Group | $0.01 | 0.00% | $178.0K |
| CNTRF | Centr Brands | $0.01 | 0.00% | $139.2K |
Top Matchups by Market Cap
Companies closest to CBD of Denver in market capitalization — the most meaningful head-to-head comparisons.
Scotts Miracle-Gro
MCap: $3.54B
Curaleaf Holdings
MCap: $1.80B
Turning Point Brands
MCap: $1.73B
Green Thumb Industries
MCap: $1.54B
Innovative Industrial Properties
MCap: $1.48B
Cross-Sector Comparisons
Top cannabis companies outside the CBD sector. Compare across different business models and market segments.
Jazz Pharmaceuticals
MCap: $10.99B
Scotts Miracle-Gro
MCap: $3.54B
Curaleaf Holdings
MCap: $1.80B
Turning Point Brands
MCap: $1.73B
Green Thumb Industries
MCap: $1.54B
Comparing CBDD in the Cannabis Market
CBD of Denver (CBDD) is a CBD-sector cannabis company trading at $43.74 per share with a market capitalization of $3.21B. Among its CBD peers, CBDD ranks first by market cap, with trailing twelve-month revenue of $1.22B and a gross margin of 2.1%. The stock has moved +2.70% in the current session, trading on the OTC exchange.
When comparing CBDD against other cannabis stocks, investors should consider key financial metrics including price-to-sales ratio (6.7x), revenue growth (+41.80% YoY), and balance sheet strength (cash of $264.3M vs. debt of $536.0M). The comparison tables above allow you to evaluate CBD of Denver relative to 11 sector peers and leading companies across all cannabis sub-sectors, helping you identify which stocks offer better value, stronger growth, or more favorable risk profiles.
Frequently Asked Questions
How does CBDD compare to other CBD stocks?+
What is CBDD's biggest competitor?+
Is CBDD overvalued compared to its peers?+
Which cannabis stock has better margins than CBDD?+
Can I compare CBDD to stocks in other cannabis sectors?+
Related Pages
Disclaimer: The comparison data on this page is for informational purposes only and does not constitute financial advice, investment recommendations, or an endorsement of any security. Cannabis stocks are highly volatile and subject to unique regulatory risks. Always conduct your own research and consult a licensed financial advisor before making investment decisions.Cannabismarketcap does not guarantee the accuracy or completeness of any data presented.